Beyond Checkpoint Inhibitors: Ernexa Therapeutics on ERNA-101's Novel Cell Therapy Approach

Immunologically "cold" tumors remain one of the greatest challenges in oncology, limiting the effectiveness of checkpoint inhibitors in cancers such as pla...

August 06, 2026 | Thursday | Interview
IQVIA and Medera Partner to Advance Cardiac Gene Therapy Development

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healt...

August 06, 2026 | Thursday | News
Sanofi’s MenQuadfi Gains EU Approval for Infants From Six Weeks of Age

Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease Sanofi announced that the Europ...

August 05, 2026 | Wednesday | News
Nurix Therapeutics Enrols First Patient in Phase 3 DAYBreak CLL-306 Trial for Bexobrutideg

Nurix Therapeutics, Inc.  announced that the first patient has been enrolled in the global Phase 3 DAYBreak CLL-306 study (NCT07516093) evaluating b...

August 05, 2026 | Wednesday | News
SciSparc Highlights NeuroThera’s Quantum Analytics Milestone for Clinical Trial Data

SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”),  announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a ...

August 04, 2026 | Tuesday | News
Delivering Genetic Medicines Where They Matter Most

Targeted genetic medicines are reshaping the future of cancer treatment by improving the precision of therapeutic delivery while addressing the challenges ...

August 03, 2026 | Monday | Expert Opinion
Dasher Neuroscience Completes Phase 2 Enrollment for YA-101 in Multiple System Atrophy Trial

Dasher Neuroscience Holdings Inc. (TPEx: 7829) ("Dasher Neuroscience"), an AI-driven biopharmaceutical company focused on central nervous system (CNS) dr...

July 31, 2026 | Friday | News
Lundbeck Receives FDA Fast Track Designation for Narcolepsy Candidate Lu AH69593

Lundbeck announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Lu AH69593, the company's lead oral orexin 2 rece...

July 27, 2026 | Monday | News
Accord BioPharma Launches Interchangeable Denosumab Biosimilars OSVYRTI and JUBEREQ in the U.S.

Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology and c...

July 27, 2026 | Monday | News
Synaptiq Therapeutics Launches to Advance SYN-001 for 22q11DS Neuropsychiatric Symptoms

A consortium of European and US-based investors and Nobias Therapeutics announced the launch of Synaptiq Therapeutics, a privately held, clinical-stage bio...

July 27, 2026 | Monday | News
ArkBio Completes Healthy Volunteer Dosing in Phase I Trial of Long-Acting Influenza Candidate AK0406

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") announced that all cohorts of healthy volunteers have been dosed in an Australian Phase I trial with AK...

July 27, 2026 | Monday | News
Strengthening Global Outbreak Preparedness with Next-Generation Diagnostics

The recent Bundibugyo Ebola virus outbreak underscored the limitations of relying solely on highly targeted diagnostics, highlighting the need for more ada...

July 23, 2026 | Thursday | Expert Opinion
Revvity Launched Signals for Startups to Support Early-Stage Biotechs

  Enterprise-grade Signals software with guided onboarding positioned specifically for early-stage biotechs Science-first setup with ready-to-use...

July 23, 2026 | Thursday | News
arcoris bio Partnered with Europa Biosite to Expand immunoMUSE® Kit Distribution

arcoris bio, a Swiss life science research tools and in vitro diagnostics company, announced a distribution partnership with Europa Biosite, a leading di...

July 23, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close